Skip to main content

A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR┬┐CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (LUCERNE)

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Genentech, Inc.

Start Date

December 3, 2018

End Date

July 31, 2024
 

Administered By

Ophthalmology

Awarded By

Genentech, Inc.

Start Date

December 3, 2018

End Date

July 31, 2024